Metabolic effects of polycystic ovary syndrome in adolescents

키워드

참고문헌 (40)

1. Knochenhauer ES, "Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study", J Clin Endocrinol Metab, 83, pp.3078~3082 (1998)
2. 변은경, "서울지역 여자대학생에서 다낭성난소증후군의 유병률", Endocrinology and Metabolism, 20(2), pp.120~126 (2005), 대한내분비학회
3. Zawadzki JK, "Polycystic ovary syndrome", pp.377~384 (1992), Blackwell Scientific Publications
4. Rotterdam ESHRE, "ASRM-Sponsored PCOS consensus workshop group", Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), 2004, pp.19, 41~47
5. Coviello AD, "Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance", J Clin Endocrinol Metab, 91, pp.492~497 (2006)
6. Glueck CJ, "Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome", Metabolism, 52, pp.908~915 (2003)
7. Pasquali R, "The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women", Clin Endocrinol (Oxf), 39, pp.1~16 (1993)
8. Norman RJ, "Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome", Hum Reprod, 16, pp.1995~1998 (2001)
9. Manco M, "Insulin dynamics in young women with polycystic ovary syndrome and normal glucose tolerance across categories of body mass index", PloS One, 9, pp.e92995~ (2014)
10. Vermeulen A, "A critical evaluation of simple methods for the estimation of free testosterone in serum", J Clin Endocrinol Metab, 84, pp.3666~3672 (1999)
11. Escobar-Morreale HF, "Epidemiology, diagnosis and management of hirsutism: a consensus statement by the androgen excess and polycystic ovary syndrome society.", Hum Reprod Update, 18, pp.146~170 (2012)
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)", JAMA, 285, pp.2486~2497 (2001)
13. Dunaif A., "Insulin action in the polycystic ovary syndrome", Endocrinol Metab Clin North Am, 28, pp.341~359 (1999)
14. Silfen ME, "Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS):comparison between nonobese and obese adolescents", J Clin Endocrinol Metab, 88, pp.4682~4688 (2003)
15. Grulet H, "Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome", Clin Endocrinol (Oxf), 38, pp.621~626 (1993)
16. Dunaif A., "Insulin Resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis", Endocr Rev, 18, pp.774~800 (1997)
17. Wild RA, "Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome", J Clin Endocrinol Metab, 61, pp.946~951 (1985)
18. Sozen I, "Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome", Obstet Gynecol Surv, 55, pp.321~328 (2000)
19. Diamanti-Kandarakis E, "Pathophysiology and types of dyslipidemia in PCOS", Trends Endocrinol Metab, 18, pp.280~285 (2007)
20. Dejager S, "Smaller LDL particle size in women with polycystic ovary syndrome compared to controls", Clin Endocrinol (Oxf), 54, pp.455~462 (2001)
21. Orio F Jr, "The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study", J Clin Endocrinol Metab, 89, pp.3696~3701 (2004)
22. Legro RS, "Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women", J Clin Endocrinol Metab, 84, pp.165~169 (1999)
23. Arslanian SA, "Glucose intolerance in obese adolescents with polycystic ovary syndrome:roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease", J Clin Endocrinol Metab, 86, pp.66~71 (2001)
24. Edman CD, "Effect of obesity on coriversion of plasma androstenedione to estrone in ovulatory and anovulatory young women", Am J Obstet Gynecol, 130, pp.456~461 (1978)
25. Nestler JE, "A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome", J Clin Endocrinol Metab, 72, pp.83~89 (1991)
26. Economou F, "In overweight", obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls, 2009, pp.8, 199~206
27. Al-Hakeim HK., "Correlation Between Iron Status Parameters and Hormone Levels in Women with Polycystic Ovary Syndrome", Clin Med Insights Womens Health, 5, pp.1~8 (2012)
28. Supriya P, "Body iron status and association with hyperinsulinaemia and hyperandrogenism in non-obese Indian women with polycystic ovarian syndrome", J Clin Sci Res, 1, pp.2~7 (2012)
29. Berria R, "Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome", Clin Pharmacol Ther, 80, pp.105~114 (2006)
30. Coviello AD, "Effects of graded doses of testosterone on erythropoiesis in healthy young and older men", J Clin Endocrinol Metab, 93, pp.914~919 (2008)
31. Claustres M, "Androgen and erythropoiesis:evidence for an androgen receptor in erythroblasts from human bone marrow cultures", Horm Res, 29, pp.17~22 (1988)
32. Yip R, "Recommendations to prevent and control iron deficiency in the United States", MMWR Recomm Rep, pp.i-29~ (1998)
33. Bitzer J, "Gynecological care in young women: a high-risk period of life", Gynecol Endocrinol, 30, pp.542~548 (2014)
34. Friedland O, "Obesity and lipid profiles in children and adolescents", J Pediatr Endocrinol Metab, 15, pp.1011~1016 (2002)
35. Steinberger J, "Relationship between insulin resistance and abnormal lipid profile in obese adolescents", J Pediatr, 126, pp.690~695 (1995)
36. Park HR, "The metabolic syndrome in young Korean women with polycystic ovary syndrome", Diabetes Res Clin Pract, 77(Suppl 1), pp.S243~S246 (2007)
37. Chae SJ, "Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women", Hum Reprod, 23, pp.1924~1931 (2008)
38. Lobo RA, "The importance of diagnosing the polycystic ovary syndrome", Ann Intern Med, 132, pp.989~993 (2000)
39. Macut D, "Cardiovascular risk in adolescent and young adult obese females with polycystic ovary syndrome (PCOS)", J Pediatr Endocrinol Metab, 14(Suppl 5), pp.1353~1359 (2001)
40. Legro RS, "Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 98, pp.4565~4592 (2013)

관련 논문AI추천